Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Cytomegalovirus Infection

Free Subscription Articles published in Clin Transplant Retrieve available abstracts of 19 articles: HTML format

Single Articles

March 2022
1. HIDAKA Y, Goto N, Yamanaga S, Kinoshita K, et al
   Two-year outcomes of low-exposure extended-release tacrolimus and mycophenolate mofetil regimen in de novo kidney transplantation: A multi-center randomized controlled trial.
   Clin Transplant. 2022 Mar 28:e14655. doi: 10.1111/ctr.14655.
   PubMed     Abstract available
   
   
   
2. NGUYEN A, Finci L, Berney T, Tonoli D, et al
   Letermovir for cytomegalovirus primary prophylaxis in a multiple abdominal/ small bowel transplant recipient.
   Clin Transplant. 2022 Mar 2:e14624. doi: 10.1111/ctr.14624.
   PubMed    
   
   
   January 2022
3. MEHTA RB, Shimko K, Zhang X, Puttarajappa C, et al
   Rabbit antithymocyte globulin dose and early subclinical and clinical rejections in kidney transplantation.
   Clin Transplant. 2022 Jan 9:e14582. doi: 10.1111/ctr.14582.
   PubMed     Abstract available
   
   
   
4. BRAR S, Berry R, Raval AD, Tang Y, et al
   Outcomes among CMV-mismatched and highly sensitized kidney transplants recipients who develop neutropenia.
   Clin Transplant. 2022 Jan 4:e14583. doi: 10.1111/ctr.14583.
   PubMed     Abstract available
   
   
   December 2021
5. AFZAL A, Alam A, van Zyl JS, Zafar H, et al
   Observed Elevated Donor-Derived Cell Free DNA in Orthotopic Heart Transplant Recipients Without Clinical Evidence of Rejection.
   Clin Transplant. 2021 Dec 4:e14549. doi: 10.1111/ctr.14549.
   PubMed     Abstract available
   
   
   November 2021
6. ORTIZ F, Lempinen M, Aaltonen S, Koivuviita N, et al
   Letermovir treatment for CMV infection in kidney and pancreas transplantation: a valuable option for complicated cases.
   Clin Transplant. 2021 Nov 19:e14537. doi: 10.1111/ctr.14537.
   PubMed     Abstract available
   
   
   July 2021
7. JORGENSON MR, Descourouez JL, Leverson GE, Saddler CM, et al
   A Pilot Study of an Intensified Ganciclovir Dosing Strategy for Treatment of Cytomegalovirus Disease in Kidney and/or Pancreas Transplant Recipients.
   Clin Transplant. 2021 Jul 15. doi: 10.1111/ctr.14427.
   PubMed     Abstract available
   
   
   June 2021
8. RHO E, Naf B, Tf M, Rp W, et al
   Use of Letermovir-Valganciclovir combination as a step-down treatment after Foscarnet for Ganciclovir-resistant CMV infection in kidney transplant recipients.
   Clin Transplant. 2021 Jun 28. doi: 10.1111/ctr.14401.
   PubMed     Abstract available
   
   
   
9. JORGENSON MR, Marka N, Leverson GE, Smith JA, et al
   Valganciclovir Prophylaxis Extension from 3 to 6 Months in High Risk Pancreas Transplant Recipients Does Not Impact Incidence of Cytomegalovirus Infection at 12 months.
   Clin Transplant. 2021 Jun 2:e14379. doi: 10.1111/ctr.14379.
   PubMed     Abstract available
   
   
   May 2021
10. DURST MM, Jorgenson MR, Descourouez JL, Saddler CM, et al
    Bimonthly viral monitoring for late-onset cytomegalovirus infection-Balancing efficacy with patient palatability; A reply to Melgarejo et al.
    Clin Transplant. 2021 May 21:e14348. doi: 10.1111/ctr.14348.
    PubMed    
    
    
    March 2021
11. VEIT T, Pan M, Munker D, Arnold P, et al
    Association of CMV-specific-T-cell immunity and risk of CMV infection in lung transplant recipients.
    Clin Transplant. 2021 Mar 22:e14294. doi: 10.1111/ctr.14294.
    PubMed     Abstract available
    
    
    
12. RAHIMISHAHMIRZADI M, Jevnikar AM, House AA, Luke PP, et al
    Late-onset Allograft Rejection, Cytomegalovirus Infection and Renal Allograft Loss: Is Anti-CMV Prophylaxis Required Following Late-onset Allograft Rejection?
    Clin Transplant. 2021 Mar 13:e14285. doi: 10.1111/ctr.14285.
    PubMed     Abstract available
    
    
    February 2021
13. MELGAREJO I, Jorgensen D, Hariharan S, Puttarajappa CM, et al
    Bimonthly Viral Monitoring for Late-Onset Cytomegalovirus infection in Kidney Transplant Recipients.
    Clin Transplant. 2021 Feb 19:e14259. doi: 10.1111/ctr.14259.
    PubMed     Abstract available
    
    
    January 2021
14. VON STEIN L, Leino AD, Pesavento T, Rajab A, et al
    Antithymocyte induction dosing and incidence of opportunistic viral infections using steroid-free maintenance immunosuppression.
    Clin Transplant. 2021;35:e14102.
    PubMed     Abstract available
    
    
    April 2020
15. ANDERSON A, Raja M, Vazquez N, Morris M, et al
    Clinical "real-world" experience with letermovir for prevention of cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.
    Clin Transplant. 2020 Apr 3:e13866. doi: 10.1111/ctr.13866.
    PubMed     Abstract available
    
    
    March 2020
16. LAUB MR, Byrns J, Gommer J, Ellis M, et al
    Delayed versus initial cytomegalovirus prophylaxis after kidney transplantation.
    Clin Transplant. 2020 Mar 12:e13854. doi: 10.1111/ctr.13854.
    PubMed     Abstract available
    
    
    January 2020
17. JORGENSON MR, Descourouez JL, Lyu B, Astor BC, et al
    Management of BK Viremia is Associated with a Lower Risk of Subsequent Cytomegalovirus Infection in Kidney Transplant Recipients.
    Clin Transplant. 2020 Jan 29:e13798. doi: 10.1111/ctr.13798.
    PubMed     Abstract available
    
    
    November 2019
18. ASANTE-KORANG A, Carapellucci J, Krasnopero D, Brown B, et al
    Resource Utilization of Cytomegalovirus Immune Globulin in Prevention and Treatment of Cytomegalovirus infection in Pediatric Heart Transplantation.
    Clin Transplant. 2019 Nov 6. doi: 10.1111/ctr.13750.
    PubMed     Abstract available
    
    
    March 2019
19. HEMMERSBACH-MILLER M, Alexander BD, Sudan DL, Pieper C, et al
    Infections after Kidney Transplantation. Does Age Matter?
    Clin Transplant. 2019 Mar 8:e13516. doi: 10.1111/ctr.13516.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: